NCT00044876View on ClinicalTrials.gov

Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 2, 2002

Primary Completion Date

June 16, 2007

Study Completion Date

October 1, 2015

Conditions
Leiomyoma
Interventions
DRUG

CDB-2914

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00044876 - Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist | Biotech Hunter | Biotech Hunter